An MS relapse and the end of a relationship leave columnist Ahna Crum feeling unsafe and unsure about the world around her.

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...

Jill Blackburn, a pediatric MS mom, founded the Pediatric Multiple Sclerosis Alliance to help other families of kids with the ...

Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...

Compassion means listening to your body without guilt and sometimes avoiding just "pushing through," writes columnist.

Learn about workplace accommodations for MS, your rights under the ADA, and practical tips for managing multiple sclerosis at ...

Researchers have identified two experimental medications that may be able to promote myelin repair in people with MS, a study ...

The Valhalla Foundation awarded Octave Bioscience funding to further develop a biomarker blood test for assessing disease ...

Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

With FDA-requested toxicology reports in hand, Quantum is preparing to seek clearance for stating the first trial of Lucid-MS ...